Evidence map›Paper›PMID 36077551›Full record

ArticleInternational journal of molecular sciences2022

Serum Proteome Signatures of Anti-SARS-CoV-2 Vaccinated Healthcare Workers in Greece Associated with Their Prior Infection Status.

Eleni Stamoula, Eleana Sarantidi, Vasilis Dimakopoulos, Alexandra Ainatzoglou, Ioannis Dardalas, Georgios Papazisis, Konstantina Kontopoulou, Athanasios K Anagnostopoulos

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Global Proteomic Profiling to Unravel Lipofuscin's Protein Repertoire.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  5. Article
  6. The Impact of Serum/Plasma Proteomics on SARS-CoV-2 Diagnosis and Prognosis.International journal of molecular sciences · 2024
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Eleni StamoulaDepartment of Biotechnology, Centre of Systems Biology, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.ORCID 0000-0002-8952-821X
Eleana SarantidiDepartment of Biotechnology, Centre of Systems Biology, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
Vasilis DimakopoulosDepartment of Biotechnology, Centre of Systems Biology, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
Alexandra AinatzoglouDepartment of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Ioannis DardalasDepartment of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Georgios PapazisisDepartment of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.ORCID 0000-0003-1641-9095
Konstantina KontopoulouLaboratory of Microbiology, "G. Gennimatas" General Hospital, 54635 Thessaloniki, Greece.ORCID 0000-0001-5191-568X
Athanasios K AnagnostopoulosDepartment of Biotechnology, Centre of Systems Biology, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.ORCID 0000-0001-5161-7850
Aristotle University of Thessaloniki · GRBiomedical Research Foundation of the Academy of Athens · GRGeneral Hospital of Athens G. Genimatas · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the course of the pandemic, proteomics, being in the frontline of anti-COVID-19 research, has massively contributed to the investigation of molecular pathogenic properties of the virus. However, data on the proteome on anti-SARS-CoV-2 vaccinated individuals remain scarce. This study aimed to identify the serum proteome characteristics of anti-SARS-CoV-2 vaccinated individuals who had previously contracted the virus and comparatively assess them against those of virus-naïve vaccine recipients. Blood samples of

Indexed as

BNT162 VaccineCOVID-19ProteomeAntibodies, ViralChromatography, LiquidGreeceHealth PersonnelHumansSARS-CoV-2Tandem Mass SpectrometryAntibodies, ViralBNT162 VaccineProteomeCOVID-19LC-MS/MSproteomicsSARS-CoV-2serumvaccination

Identifiers

PMID36077551
PMCPMC9456361
OpenAlexW4294733751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.